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INTRODUCTION
Pneumonia is a severe disease associ-
ated with high morbidity and mortality
(1). In the United States, nearly 100,000
deaths are attributed to pneumonia and
sepsis per year, making these the fifth
leading causes of death (2). The Gram-
negative bacterium Klebsiella (K.) pneumo-
niae is a common causative pathogen in
pneumonia (3–5).
The innate immune system provides
the first immunological interface be-
tween the host and invading pathogens.
Pattern recognition receptors (PRRs) ex-
pressed by immune cells can detect
conserved motifs present in microor-
ganisms termed pathogen-associated
molecular patterns (PAMPs), thereby
initiating an inflammatory response de-
signed to eliminate the intruder (6). In
Gram-negative pneumonia, Toll-like re-
ceptors (TLRs) recognize several
PAMPs, including lipopolysaccharide
(LPS) (TLR4), DNA (TLR9), RNA
(TLR3), Porins/peptidoglycan (TLR2)
and flagellin (TLR5) (7,8). NOD-like re-
ceptors (NLRs) may interact with DNA
(AIM2) (9), peptidoglycan (NOD2,
NALP1/3) and flagellin (IPAF) (9,10).
Multiple PRRs detect their respective
PAMPs simultaneously and interplay
between pathways is highly likely to
arise during an evolving infection
(7,11).
Reversible phosphorylation, medi-
ated by protein kinases and phos-
phatases, regulates signal transduction
pathways (12). The outcome of these
phospho-transfer activities is beyond
the simple linear signal transduction
models. A broader perspective of this
complex system is enabled by array
techniques. Kinome profiling represents
a method to obtain activity data of ki-
nases and their respective pathways
(13). Here, we utilized a kinase activity
array with 1,024 consensus sequences to
reveal sequential processes during the
course of K. pneumoniae pneumonia in
mice. We identified and validated activ-
ity patterns of classic immune-related
kinases, such as p38  mitogen-activated
protein kinase (p38) and p42 mitogen-
activated protein kinase (p42), as well
as other key regulators of cellular re-
sponses such as glycogen synthase ki-
nase 3β (GSK-3β) and the v-src sarcoma
(Schmidt-Ruppin A-2) viral oncogene
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Pneumonia is a severe disease with high morbidity and mortality. A major causative pathogen is the Gram-negative bacterium
Klebsiella (K.) pneumoniae. Kinases play an integral role in the transduction of intracellular signaling cascades and regulate a
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murine Gram-negative pneumonia using a systems biology approach. Kinase activity arrays enable the analysis of 1,024 con-
sensus sequences of protein kinase substrates. Using a kinase activity array on whole lung lysates, cellular kinase activities were
determined in a mouse model of K. pneumoniae pneumonia. Notable kinase activities also were validated with phospho-spe-
cific Western blots. On the basis of the profiling data, mitogen-activated protein kinase (MAPK) signaling via p42 mitogen-acti-
vated protein kinase (p42) and p38 mitogen-activated protein kinase (p38) and transforming growth factor β (TGFβ) activity
were reduced during infection, whereas v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) activity
generally was enhanced. AKT signaling was represented in both metabolic and inflammatory (mitogen-activated protein kinase
kinase 2 [MKK], apoptosis signal-regulating kinase/mitogen-activated protein kinase kinase kinase 5 [ASK] and v-raf murine sar-
coma viral oncogene homolog B1 [b-RAF]) context. This study reaffirms the importance of classic inflammation pathways, such
as MAPK and TGFβ signaling and reveals less known involvement of glycogen synthase kinase 3β (GSK-3β), AKT and SRC signal-
ing cassettes in pneumonia.
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Female C57Bl6 mice (aged 10 wks)
were purchased from Charles River (Maas-
tricht, the Netherlands). The Animal Care
and Use Committee of the University of
Amsterdam approved all experiments.
Induction of Pneumonia/Inflammation
Bacterial pneumonia was induced as
described previously (11,14). K. pneumo-
niae serotype 2 (ATCC 43816) were
grown in Tryptic Soy broth (Difco, De-
troit, MI, USA) to midlogarithmic phase
at 37°C. Bacterial cultures were har-
vested by centrifugation at 2,900g for 
15 min, washed twice and resuspended
in sterile saline at a concentration of 
104 CFU/ 50 μl. Mice were inoculated
with 50 μl of bacterial suspensions in-
tranasally under isoflurane  (Upjohn,
Ede, the Netherlands) inhalation anes-
thesia. Control mice were intranasally
inoculated with sterile saline.
Determination of Bacterial Load
At 3, 6, 24 and 48 h after infection, three
mice were euthanized by cardiac punc-
ture under Domitor (Pfizer Animal Health
Care, Capelle aan den IJssel, the Nether-
lands; active ingredient medetomidine)
and Nimatek (Eurovet Animal Health,
Bladel, the Netherlands; active ingredient
ketamine) anesthesia. Three control mice
were euthanized 3 h after inoculation
with sterile saline. Left lungs were har-
vested and homogenized in four volumes
of sterile saline with a tissue homogenizer
(ProScience, Oxford, CT, USA). Colony
forming units (CFUs) were determined
from serial dilutions of samples, plated on
blood agar plates and incubated at 37°C
for 16 h before colonies were counted.
Kinome Profiling
Right lungs were snap frozen in liq-
uid nitrogen, after which they were ho-
mogenized in three volumes of lysis
buffer (MPER; Pierce, Rockville, WI,
USA)  supplemented with 1 mmol/L
MgCl2, 1 mmol/L glycerophosphate,
1 mmol/L Na3VO4, 1 mmol/L NaF,
1 μg/mL leupeptin, 1 μg/mL aprotinin
and 1 mmol/L phenylmethylsulphonyl
fluoride. Homogenates were centrifuged
at 2,080g for 5 min and pellets were dis-
carded. Samples were pooled and di-
luted to a protein concentration of
1 mg/mL. Of these lysates, 80 μL were
mixed with 12 μL of Activation mix
(70 mmol/L MgCl2, 70 mmol/L MnCl2,
400 μg/mL PEG 8000 and 47μCi 
[33P-γ]ATP) and applied to the array
(Pepscan Presto, Lelystad, the Nether-
lands). The arrays chips were incubated
at 37°C for 2 h and were washed twice
in 2 mol/L NaCl (1% TWEEN 20), once
in PBS (1% SDS) and rinsed twice in
demineralized H2O. After air drying, the
chips were exposed to a phosphor im-
ager plate for 72 h. [33P-γ]ATP signals
were measured with a phosphor imager
(Storm, Amersham Biosciences, Uppsala,
Sweden).
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Figure 1. Heat map and clustering of phosphorylation states of 179 significantly altered kinase activities in whole lung lysates (A). Note
that the distance between the cluster of infection and control is the greatest. Venn diagram (B) depicting the distribution of phosphory-
lated spots at time points indicated; 3 h is depicted in blue, 6 h in yellow, 24 h in green and 48 h in red. Most data points are confined to
their respective time points. pRB, retinoblastoma kinase; N/A, not available (this spot has no consensus upstream kinase).
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Analysis
Spot densities and individual back-
grounds were analyzed using Scanalyse
(http://rana.lbl.gov/EisenSoftware.htm).
Data were exported to a spreadsheet for
further analysis. The raw data were nor-
malized to the 90th percentile, as de-
scribed previously (15–18). From this
data, the heat map in Figure 1 was con-
structed in R 2.12.0 (R Foundation for
Statistical Computing, Vienna, Austria)
using the heatmap.2 function of the
gplots library, making use of the hclust
function set using complete-linkage. 
Significance was assessed by Student 
t test on normalized data. Shared event
distribution was visualized using Venny




Results from the kinome analysis
were validated by performing phospho-
specific Western blots for major kinases.
Blots were done for pp38–mitogen-
 activated protein kinase (pp38-MAPK),
pp42/44-MAPK, pSMAD1/5/8, pSRC
and pGSK-3β (Cell Signaling Technol-
ogy, Boston, MA, USA) and β-actin
(Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Samples for Western blotting
were boiled at 95°C for 5 min in
Laemmli buffer and loaded onto SDS-
PAGE gels. After electrophoresis, the
content of the gels was transferred onto
Immobilon-PVDF membranes (Milli-
pore, Billerica, MA, USA). Membranes
were blocked in 5% bovine serum albu-
min (BSA) (Roche, Basel, Switzerland)
in Tris buffered saline Tween (TBS-T) at
room temperature for 60 min. All anti-
bodies were diluted 1:500 with excep-
tion of β-actin, which was diluted
1:4000, and incubated overnight at 4°C.
Next, the membranes were incubated
for 60 min with antirabbit–horseradish
peroxidase (HRP)–conjugated secondary
antibody (Cell Signaling Technology)
and blots were imaged using LumiLight
Plus ECL (Roche) on a LAS 3000 chemi-
luminescence imager (Fujifilm, Tokyo,
Japan).
Cytokine and Chemokine Assays
For cytokine and chemokine measure-
ments, left lungs were excised, weighed
and homogenized in four volumes of
saline. Homogenates were diluted 1:2 
in lysis buffer (300 mmol/L NaCl, 
30 mmol/L Tris, 2 mmol/L MgCl2, 
2 mmol/L CaCl2, 2 % Triton X-100,
AEBSF[4-(2-aminoethyl)benzeensolfonyl
fluoride], EDTA-Na2, 8 μg/mL pepstatin
and leupeptin, pH7.4) and incubated on
ice for 30 min. Homogenates were cen-
trifuged at 2,350g at 4°C for 10 min and
stored at –20°C until use. Interleukin
(IL)-1β, IL-6, tumor necrosis factor-α
(TNF-α), cytokine-induced neutrophil
chemoattractant (KC) and macrophage
inflammatory protein (MIP)-2 were mea-
sured in lung homogenates using
 enzyme-linked immunosorbent assays
(ELISAs) (R&D Systems, Minneapolis,
MN, USA) according to the manufac-
turer’s instructions. Detection limits were:
TNF-α, 62.5 pg/mL; MIP-2 and KC, 
15 pg/mL; IL-1β and IL-6: 31.25 pg/mL.
RESULTS
Induction of Pneumonia
Mice inoculated with 104 CFU K. pneu-
moniae developed pneumonia. Table 1
represents the bacterial loads in whole
lung homogenates during the course of
the experiment. Both CFU counts and
 cytokine/chemokine levels increased
rapidly in time. Notably, this infectious
dose results in approximately 80% lethal-
ity, starting from 48 h after infection
(11,14). Hence, this model represents se-
vere pneumonia, and samples were ob-
tained from shortly after infection until
shortly before the first deaths occurred.
K. pneumoniae Pneumonia Kinome
Profile
From the phosphorylation events of the
array, a heat map was constructed (Fig-
ure 1A). The clustering of the significant
events on the array chip showed that the
kinase activity profiles of infected lungs
were more similar to each other than
those of the uninfected control animals.
The highest similarity was between sam-
ples obtained after 6 and 24 h. When com-
pared with control arrays, a total of 179
phosphorylated spots from arrays derived
from infected lungs were statistically sig-
nificantly different. For the 3, 6, 24 and
48 h time points, the spots were distrib-
uted as 82, 53, 54 and 54 differentially
phosphorylated spots, respectively (Fig-
ure 1B). The majority of events, however,
were exclusive to a single time point.
Provisional signaling cascade schemes
were created from notable phosphory-
lated spots of the kinomics chips reflect-
ing kinase activity during progressive
Gram-negative pneumonia (Figure 2).
AKT was present in the context of a
number of signaling cascades (Figure
2A). AKT is a substrate to pyruvate de-
hydrogenase kinase (PDK) (19) (spot 934)
and via GSK-3β (spots 84, 443 and 1020)
(20) and tuberin (spot 373) signals to-
ward mammalian target of rapamycin
(mTOR) (21). Moreover, AKT is involved
in the apparent downregulation of activ-
ity of kinases critical in the immune re-
sponse setting; via v-raf murine sarcoma
viral oncogene homolog B1 (b-RAF)
Table 1. Bacterial loads and cytokine and chemokine levels in lung homogenates.a,b
3 h 6 h 24 h 48 h
CFU/lung 4.6 × 103 ± 2.6 × 103 9.1 × 10 ± 2.7 × 103 3.1 × 104 ± 8.1 × 103 3.5 × 106 ± 1.2 × 106
TNF-α (pg/mL) 501 ± 230 402 ± 110 905 ± 302 1,658 ± 904
IL-1β (pg/mL) 79 ± 54 84 ± 36 414 ± 210 484 ± 66
IL-6 (pg/mL) 159 ± 69 174 ± 45 510 ± 136 1,920 ± 1,631
KC (pg/mL) 1,885 ± 460 2,809 ± 972 9,451 ± 2,614 28,202 ± 781
MIP-2 (pg/mL) 3,325 ± 887 3,237 ± 659 5,459 ± 1,186 9,397 ± 4,807
aAfter inoculation of 104 CFU of K. pneumoniae, both bacterial loads and cytokine and
chemokine levels increase with time.
bData are mean ± SD of three mice per time point.
(spots 318, 885) (22) and mitogen-activated
protein kinase kinase 2 (MEK) (spot 497)
(23) the activity of p42 MAPK (spots 49,
183, 290 and 988) was inhibited overall.
Inhibition of p38 MAPK (spots 261 and
603) could be due to AKT- dependent
modulation of apoptosis signal-regulating
kinase/ mitogen- activated protein kinase 5
(ASK) (spot 365) (24). The activity pat-
terns of serum/glucocorticoid regulated
kinase (SGK) (spot 213) and transform-
ing growth factor β (TGFβ) (spot 870) are
in agreement with lowered immune re-
sponses (25,26). Downstream of TGFβ,
SMAD1 (27) activity was diminished
after 3 and 6 h of infection.
Heat shock 22kDa protein 8 (HSP22)
(spots 61 and 529) and cyclic guanosine
monophosphate kinase 1 (cGMPk1) (spot
28) are representative of tissue damage,
arising as a consequence of uncontrolled
infection (28–30). Phosphorylation of
these substrates was enhanced very early
in infection, although HSP22 phosphory-
lation (increased 3 h after infection) was
reduced significantly at 6 h of infection.
Figure 2B depicts signaling events cen-
tered by SRC (spots 52, 590 and 736). The
SRC kinases protooncogene tyrosine-
 protein kinase Fyn (FYN) (spots 196 and
318) and leukocyte-specific protein tyro-
sine kinase (LCK) (spots 59 and 457) dis-
play enhanced activity after 24 and 48 h
respectively (17,31,32). SRC-inhibiting ki-
nase c-src tyrosine kinase (CSK) (spot 836)
(33) activity was diminished after 6 and
24 h, intermediate between CSK and SRC,
v-yes-1 Yamaguchi sarcoma viral-related
oncogene homolog (LYN) (spot 11) (34)
activity was enhanced after 48 h. These
signals toward SRC balance out and result
in overall activation of SRC  kinase.
RHO signaling (spots 613 and 850),
which is connected to SRC signaling also
was activated (35). This activation most
likely occurs via focal adhesion kinase
(FAK) (spot 340) and protein kinase C
(PKC) (spot 170) (36,37).
Validation of Kinome Profile Events
GSK-3β activity was present in the
context of AKT signaling, and shown in
the provisional signaling scheme signal-
ing toward mTOR (see Figure 2A). To
overlay the phosphorylation pattern of
the Western blot and the activity pattern
of the kinome profile, both data sets
were normalized to the control. As phos-
phorylation of GSK-3β (Figure 3A, B) at
serine 9 results in inactivation of this ki-
nase (38), normalized Western blot data
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Figure 2. Provisional signaling cascades activated during the course of Gram-negative
pneumonia. Immunological processes defined by p42 and p38 MAPKs, TGFβ and SRC ki-
nase signaling are induced by pneumonia. HSP22 and cGMPk1 hint toward the occur-
rence of tissue damage. Also AKT and PKA axis signaling are present during K. pneumo-
niae pneumonia. PLD1, phospholipase D1.
Figure 3. Validation of GSK-3β kinomics
array signals. Western blots, performed for
SER-9 phosphorylated GSK-3β (A and B).
Phosphorylation of serine 9 results in GSK-
3β deactivation. To compare Western blot
data with kinase activity data, time
point/sham ratios for both data sets were
determined. Owing to the inhibitory out-
come of the Western blot phosphorylation
data, ratios of this set were inversed. In-
versed Western blot ratios were compared
with the time point/sham ratios of the ki-
nase activity data from the kinomics array
(C). These activity patterns overlap, show-
ing consistency between Western blot and
kinase activity array methods. Data are
mean ± SD of three mice per time point.
were inverted. The graph (Figure 3C) de-
rived from the Western blot and kinome
profiles showed similar activity patterns
validating our array findings.
As depicted in the provisional signal-
ing scheme, AKT is involved in down-
regulation of kinases critical in the im-
mune response setting, including P42
and P38 (22–24). Phosphorylation states
of p38 and p42 kinases were compared
with chip signals. p42 phosphorylation
levels (Figure 4A, B) decreased over
time, which is in accordance with the de-
termined kinase activity (Figure 4C). p38
blot revealed a reduction in phosphory-
lation levels of p38 with the exception of
the 6 h time point (Figure 4D, E).
In the kinome profile array, we found
that SMAD1 activity was reduced in the
early phase of infection (see Figure 2A).
In addition, spot 708 phosphorylation
demonstrated a similar, though not sig-
nificant pattern for SMAD5 (data not
shown). The phospho-specific Western
blot (Figure 4D, G) matched the outcome
of the kinase activity array  (Figure 4H).
SRC is the heart of the provisional cas-
cades depicted in Figure 2B. Under influ-
ence of FYN, LCK and CSK-LYN, the
overall activity was increased over time
on the kinomics chip (Figure 4J). With
the exception of the 24 h time point,
Western blot analysis revealed increasing
phosphorylation of SRC during K. pneu-
monia pneumonia  (Figure 4D, I).
DISCUSSION
Genomics array data banks are becom-
ing increasingly available to the broad
public to monitor responses or predict
outcomes of specific patient subgroups.
However, most of these data banks con-
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Figure 4. Validation of notable signals in the kinomics array. Western blots and quantifications were performed to validate notable signals
in the kinomics chip. Western blots are shown in A and D; panels B, E, G and I contain graphs of densitometric assessment of Western
blots. Kinase activity data are represented in graphs C, F, H and J. Phosphorylation patterns of p42 (A, B), p38 (D, E), SMAD1/5/8 (D, G) and
SRC (D, I) based on Western blots match the kinase activity array data (C, F, H and J respectively). Array data are presented as a mean
signal of two spots belonging to the kinase of interest. Asterisks indicate significant events in kinomics profile. Data are mean ± SD of three
mice per time point.
tain gene expression data, thus lacking in-
formation on real-time protein activities
such as phosphorylation interactions
which are fundamental to signaling cas-
cades. With 1,024 consensus substrates,
kinome profiling enables the direct deter-
mination of kinase activity. We report here
for the first time sequential alterations in
kinase activities in whole lungs during
the course of severe Gram-negative
 pneumonia.
The inherent complexity of arrays de-
mands a careful approach of determining
activity patterns of a multitude of kinase-
substrate interactions prior to drawing
conclusions on individual kinase activities.
The Western blots performed for pp38,
pp42, pSMAD1/5/8, pSRC and pGSK-3β
resulted in activity patterns similar to
those of the kinome profile, validating the
data obtained from the kinomics chip.
Differences between kinase activities
found between the kinomics chip and
phosphorylation states determined by
Western blot can be explained by differ-
ences in active kinase domains from the
kinomics assay and epitopes recognized
by the p-antibodies used in our valida-
tion Western blots.
In the kinome profile, pSMAD1 was
reduced in the early phase of infection
and enhanced at 48 hours after infection.
This hints to differential activity of the
TGFβ receptor 1 or the BMP receptor
type 1B, the kinases responsible for phos-
phorylation of SMAD1 at this site. BMP
signaling in the lung is shown to facili-
tate tissue remodeling and repair and
has been implicated as a cause of pul-
monary hypertension (39,40).
Remodeling signals could be a response
to activity of the tissue damage associ-
ated kinases HSP22 and cGMPk1 (see Fig-
ure 2A). However, under control of TGFβ,
SMAD1 immunological effects are in ac-
cordance with reduced p38 and p42 activ-
ities (see Figure 2A and Figure 4A–F) (39).
AKT (or PKB) regulates various cellular
processes, such as survival, growth, pro-
liferation, glucose uptake, metabolism
and angiogenesis (20). It also was de-
scribed as regulating TLR-dependent in-
flammatory responses in bone marrow
derived mouse neutrophils (19). On the
kinomics array, AKT activity resulted in
reduced ASK activation, thus linking this
“general organizer” to inflammatory
MAPK signaling. PKA influences various
biologic systems. In the context of MAPK
signaling, PKA has dual effects on p42 ac-
tivation. When signaling via RAF-1, PKA
mediates inhibition of p42, while PKA sig-
naling via b-RAF results in activation of
p42 (23). The PKA-b-RAF cascade found
in our kinomics arrays is in agreement
with the observed p42 kinase events.
The p38 and p42 activities were reduced
during the infection, although inflamma-
tory effectors (cytokines and chemokines)
were increased. The p38 and p42 MAPK
activation is transient (41,42). The activa-
tion dynamics of p38 and p42 could be
such that the peak of their activation has
passed already at the three-hour time
point, which is in accordance with studies
in human endotoxemia studies: after an
early peak of activation for both p38 and
p42, a reduced phosphorylation state oc-
curred (43). To investigate the full activity
dynamics of p38 and p42, in future stud-
ies, kinome analysis on earlier time points
should be performed.
GSK-3β regulates multiple cellular func-
tions, including cell structure, and gene
expression, mobility and apoptosis; addi-
tionally, GSK-3β also is an important posi-
tive regulator of inflammatory processes
(44). Inhibition of GSK-3β reduced IL-
12p40, IL-6 and TNF-α cytokine levels in
mice infected with Francisella tularensis
(45). Furthermore, TLR-induced proin-
flammatory cytokine production was re-
duced in monocytes by inhibiting GSK-3β
(44). The effects on host response by GSK-
3β are attributed to regulation of transcrip-
tion factors as NF-κB, NFAT and STATs
(46). In our data (see Figure 2) GSK-3β ac-
tivity is reduced at the three-hour time
point and enhanced at the six-hour time
point. This is in accordance with the ob-
served enhanced activity of TGFβ, which
has a known antiinflammatory effect (26)
at three hours, and the reductions in p38
and p42 activity (see Figure 2).
Knowledge of the expression of SRC ty-
rosine kinase family members during in-
fection is limited. In accordance with our
current data, enhanced SRC activity was
noted in a mouse model of LPS-induced
acute lung injury (47). Moreover, the SRC
family inhibitor PP1 blocked LPS-induced
NF-κB activation in lung tissue via down-
regulation of the phosphorylation and
degradation of IκB-α at 4 or 24 hours (36);
moreover, SRC family inhibition attenu-
ated LPS-induced acute lung injury (48)
supposedly via an effect on TLR signaling
(49). Also, CSK mutant (CSK-GEcre) mice,
which lack a general inhibitor of SRC, de-
velop acute multifocal inflammation in
skin and lung and are hypersensitive to
LPS-induced shock due to unconstrained
SRC activity (33). These findings support
the notion that the SRC-related signals
that arise from kinase activity profiling
are a direct response to ongoing infection.
Pneumonia triggers a complex host re-
sponse at the primary site of infection
that encompasses a protective innate im-
mune response aiming to kill invading
pathogens, counterregulatory actions
seeking to limit collateral tissue damage
and repair processes. Kinases are impor-
tant components of the integrated cellular
responses during pneumonia. The cur-
rent investigation is the first to provide
insight in pulmonary activity of key ki-
nases during various stages of severe
Gram-negative respiratory tract infection.
Kinase activity assays enable a direct
assessment of the dynamics of kinases
with a higher throughput than any cur-
rently available antibody-based method.
Moreover, kinase activity arrays measure
the activity of kinases on their respective
substrates, rather than providing indirect
information on their activity via their
phosphorylation state. Nonhypothesis
driven experiments, made possible by an
array approach, may facilitate observa-
tions outside of ruling paradigms.
Our results point to induction of innate
immunity, as reflected by classic p42 and
p38 MAPKs, TGFβ, the lesser-known im-
munological side of SRC kinases, and the
increasingly appreciated role of GSK-3β in
the host response. In addition, processes
controlled by general organizers such as
AKT and PKA were induced, of which
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the exact effects are more difficult to pin-
point. This study suggests a role for SRC
kinase in pneumonia and delineates a po-
tential link of AKT and PKA with inflam-
matory responses. As such, kinase activity
profiling may reveal new functional and
pathogenetic mechanisms at play during
various stages of pneumonia.
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